Prostate Cancer Drug Linked To Risk Of Dementia Unlisted Video

4 years ago
7

Patients who take a hormone-suppressing drug to treat prostate cancer may be at greater risk for dementia and Alzheimer's.
A JAMA Network study of more than 150,000 men found a link between the degenerative diseases and androgen deprivation therapy.
Researchers cautioned doctors to further consider the risks of ADT before giving it to their patients to treat prostate cancer.
According to Business Insider, the study says older men taking the treatment have a 20-percent higher chance of dementia.

Loading comments...